Cisapride: a review of the evidence supporting its use in premature infants with feeding intolerance.
A systematic computerized search of all databases was performed to review the scientific evidence in support of the efficacy of cisapride in reducing feeding intolerance in premature infants. Reference lists from these articles were used to identify relevant scientific literature to address important aspects of the use of cisapride. Three open prospective, uncontrolled studies were found. All studies reported improved clinical outcomes as evidenced by decreased gastric residuals, decreased incidence of vomiting, increased feeding volume, decrease in all reflux parameters measured, and increased weight gain. These observational studies reflect the current state of knowledge and have important research and clinical implications because of the profound effects of feeding intolerance on infant growth and development and on length of stay within NICUs.
Premji
S S
SS
Neonatal Unit 4G MUMC, Children's Hospital, Hamilton Health Sciences Corporation, Ontario. Premji@ihis.cmh.on.ca
Wilson
J
J
Paes
B
B
Gray
S
S
D020117:Cisapride; D019959:Feeding and Eating Disorders of Childhood / Q000188:drug therapy*; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D017283:Neonatal Nursing; D010880:Piperidines / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D010880:Piperidines; D012702:Serotonin Antagonists; D020117:Cisapride